WHO WE ARE
An independent health care consulting firm founded by Principals with many years of experience consulting and providing support for life sciences clients including pharmaceutical, biotechnology, device and diagnostic manufacturers, and payers.
Our Principals and Director have extensive experience in health policy working with federal clients including the U.S. Food and Drug Administration, the Department of Health and Human Services Assistant Secretary for Planning and Evaluation (ASPE), and the Centers for Disease Control and Prevention.
CONSULTING TEAM

Francine Chingcuanco, MHS
MANAGER
Francine Chingcuanco, MHS

Benjamin Cohen, PhD, MPH
MANAGER
Benjamin Cohen, PhD, MPH

Elena Fernandez, PharmD, PhD
MANAGER
Elena Fernandez, PharmD, PhD

Omar Mansour, MHS
MANAGER
Omar Mansour, MHS

Katharine Ozenberger, MS, PhDc
MANAGER
Katharine Ozenberger, MS, PhDc

Danyang Wang, MHS
SENIOR ANALYST
Danyang Wang, MHS

Karen Dietz, MHS
CONSULTANT
Karen Dietz,MHS

Ellen Hu, MHS
CONSULTANT
Ellen Hu, MHS

Divya Mohan, MHS
CONSULTANT
Divya Mohan, MHS

Emma Tassie, MS
CONSULTANT
Emma Tassie, MS

Jeromie Ballreich, PhD, MS
CONSULTANT
Jeromie Ballreich

Elisabeth H. Hazard, PhD
CONSULTANT
Elisabeth H. Hazard, PhD

You? Join Us
WORK WITH MA
TOP TALENT?
SENIOR SCIENTIFIC ADVISORS

Kim Heithoff, MPH, SCD
SENIOR SCIENTIFIC ADVISOR
Kim Heithoff, MPH, SCD

Daniel Touchette, PharmD, MA, FCCP
SENIOR SCIENTIFIC ADVISOR
Daniel Touchette, PharmD, MA, FCCP

Brett McQueen, PhD
SENIOR SCIENTIFIC ADVISOR
Brett McQueen, PhD
ADVISORY BOARD MEMBERS

Adrian Levy, PhD
ADVISORY BOARD MEMBER
Adrian Levy, PhD

Mark Sculpher, PhD
ADVISORY BOARD MEMBER
Mark Sculpher, PhD
Mark Sculpher is Professor of Health Economics at the Centre for Health Economics, University of York, UK where he leads the Centre’s Programme on Economic Evaluation and Health Technology Assessment. He is also Co-Director of the Policy Research Unit in Economic Evaluation of Health and Care Interventions, a programme of research for the UK Department of Health and Social Care funded by the National Institute for Health Research (NIHR).
Mark has worked in the field of economic evaluation and health technology assessment for over 30 years. He has researched in a range of clinical areas including heart disease, cancer, diagnostics, and public health. He has also contributed to research methods in the field, in particular relating to decision analytic modelling and techniques to handle uncertainty, heterogeneity and generalisability. He is also experienced in economic analysis in low income settings and is principle investigator of the Thanzi la Onse (Health for All) programme in Malawi funded by UK Research and Innovation. He has over 270 peer-reviewed publications and is a co-author of two major text books in the area: Methods for the Economic Evaluation of Health Care Programmes (OUP, 2015 with Drummond, Claxton, Torrance and Stoddart) and Decision Modelling for Health Economic Evaluation (OUP, 2006 with Briggs and Claxton).
Mark is an emeritus member of the UK NIHR College of Senior Investigators. Hehas also been a member of the National Institute for Health and Clinical Excellence (NICE) Technology Appraisal Committee and the NICE Public Health Interventions Advisory Committee. He currently sits on NICE’s Diagnostics Advisory Committee. He chaired NICE’s 2004 Task Group on methods guidance for economic evaluation and advised the Methods Working Party for the 2008 update of this guidance. Mark has advised the UK House of Commons Health and Social Care Select Committee, as well as health systems internationally on health technology assessment methods including those in France, Ireland, Japan, Singapore, Germany, Portugal, Taiwan and New Zealand. He has been a member of the Commissioning Board for the UK NHS Health Technology Assessment Programme, the UK NIHR /Medical Research Council’s Methodology Research Panel and the UK Department of Health’s Policy Research Programme’s Commissioning Panel. He served as President of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) (2011-12).